Sunday, August 2, 2026

North Korea’s Drone Fiasco Shot Down by ICAO—What’s Kim’s Next Move?

ICAO rejects North Korea's request to discuss alleged South Korean drone incursion, closing the matter on civil aviation safety grounds.

Psychiatrists See Promise in Generative AI for Mental Health Care, but Not as a Replacement for Clinicians

South Korean psychiatrists see generative AI as a supportive tool for mental health but caution against replacing human clinicians.

SK Plasma’s Historic 65 Million EUR Tech Export Deal: What It Means for Turkey’s Pharmaceutical Independence

SK Plasma signs a €65M tech transfer deal with Turkey to boost local production of essential medicines, enhancing global healthcare access.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

Samsung Biologics Named Dow Jones Best-in-Class World Index for Fifth Straight Year

Samsung Biologics has been recognized in the Dow Jones Best-in-Class World Index for five consecutive years, showcasing its ESG achievements.

Hugel Broadens Collaboration With Korean Clinicians Through Regional Academic Events

Hugel is enhancing its presence in the Korean aesthetics market through academic programs and expanding into Indonesia with training events.

JPI Healthcare Expands From X-Ray Components Into AI-Based Digital Imaging Solutions

JPI Healthcare evolves into an AI-driven imaging platform, enhancing X-ray technology and expanding into tailored medical solutions.

Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid Arthritis After Positive Mid-Stage Data

GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.

GF Fermentech Showcases Synthetic Biology CDMO Platform at SynBioBeta 2026

GF Fermentech showcased its CDMO platform at SynBioBeta 2026, emphasizing rapid commercialization and advanced production technologies.

Humedix Seeks Domestic Approval for PN-HA Composite Filler Valpien

Huons Group's Humedix is set to launch Valpien, a novel composite filler, improving wrinkle treatment with less pain and effective results.

JLK Secures Brazil Regulatory Clearance as It Expands AI Imaging Push in Latin America

JLK accelerates its expansion into Brazil with AI medical imaging solutions, addressing rising healthcare demands for breast cancer and stroke.

National New Drug Development Project Group Holds 2026 Workshop on Investment Review Strategy

The National New Drug Development Project Group held a workshop to discuss drug development trends and investment strategies for future projects.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

Large-Scale Real-World Study Supports Zacubo’s Efficacy and Safety in GERD Treatment

A study shows Onconic Therapeutics' Zacubo significantly improves GERD symptoms in patients unresponsive to existing treatments.

Novo Nordisk’s Oral Wegovy Just Put Up a Number That Could Change the Obesity Drug Race

Novo Nordisk's oral obesity treatment, Wegovy, saw $400M in Q1 2026 sales, exceeding estimates and indicating strong market demand.

Celltrion’s Zymfentra Just Hit a New U.S. Prescription Record and the Growth Looks Serious

Celltrion's Zymfentra treatment saw a 185% surge in U.S. prescriptions, driven by effective marketing and reimbursement strategies.

A Long-Acting Oral Drug? Yuhan’s Latest Trial Update Is Turning Heads

Yuhan Corp's YH35995 shows promising results for Gaucher disease in Phase 1 trial, demonstrating long-lasting efficacy and BBB penetration.

Korea’s First Domestic CAR-T Therapy Just Won Approval—and That’s a Bigger Deal Than It Sounds

CureCell's CAR-T therapy Rimkato is the first approved in South Korea, enhancing access to treatment for blood cancer patients.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.